5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial

BACKGROUND: Despite widespread use of short-acting antagonists for the 5-hydroxytryptamine (5-HT) receptor, about 50% of patients given moderately emetogenic chemotherapy have delayed nausea. We aimed to assess whether a 5-HT-receptor antagonist was more effective than was prochlorperazine for contr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hickok, J T, Roscoe, J A, Morrow, G R, Bole, C W, Zhao, H, Hoelzer, K L, Dakhil, S R, Moore, T, Fitch, T R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2005
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1646426/
https://ncbi.nlm.nih.gov/pubmed/16198982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(05)70325-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller